PVLA
Financials
- Market Capitalization 2.2 B
- Employee 29
- Founded N/A
- CEO N/A
- Website www.palvellatx.com
- Headquarter Nevada, United States
- FIGI BBG0055C3N57
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1590 |  OGN Organon & Co. Common Stock | 13.50 USD | 0.00% | +0.07% | +0.37% | +85.95% | 3.55 B USD | ||
| 1788 |  MBX MBX Biosciences, Inc. - Common Stock | 60.08 USD | +6.17% | -3.38% | +52.68% | +329.14% | 2.86 B USD | ||
| 2009 |  RAPP Rapport Therapeutics, Inc. - Common Stock | 40.37 USD | -2.63% | -3.35% | +5.02% | +54.14% | 1.93 B USD | ||
| 2059 |  GENB Generate Biomedicines, Inc. - Common Stock | 13.96 USD | -1.76% | -11.37% | +3.71% | -6.93% | 1.79 B USD |
Frequently asked questions about Palvella Therapeutics, Inc. - Common Stock
What is the Palvella Therapeutics, Inc. - Common Stock stock price today?
The current price of Palvella Therapeutics, Inc. - Common Stock (PVLA) is 153.53. Over the past 24 hours, the stock has changed by +2.57%. Follow the PVLA chart for real-time price dynamics.
What is the stock ticker of Palvella Therapeutics, Inc. - Common Stock?
Palvella Therapeutics, Inc. - Common Stock trades under the ticker PVLA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Palvella Therapeutics, Inc. - Common Stock stock going up?
PVLA has changed by +6.06% over the last week, +31.22% over the last month, and +107.89% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Palvella Therapeutics, Inc. - Common Stock net income for the last quarter?
Palvella Therapeutics, Inc. - Common Stock reported net income of -15.77 M for the last quarter. The previous quarter showed -12.71 M, which means net income changed by -24.01%.
How many employees does Palvella Therapeutics, Inc. - Common Stock have?
As of the latest available data, Palvella Therapeutics, Inc. - Common Stock has 29 employees. Workforce size can provide additional context about the company's scale and operations.
What is Palvella Therapeutics, Inc. - Common Stock EBITDA?
Palvella Therapeutics, Inc. - Common Stock EBITDA is -13.8 M, and its EBITDA margin is -1 285.83%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Palvella Therapeutics, Inc. - Common Stock stock?
You can buy Palvella Therapeutics, Inc. - Common Stock (PVLA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Palvella Therapeutics, Inc. - Common Stock stock?
Investing in Palvella Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PVLA chart and related analysis on metatrader.com as part of your research.